Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

The conference highlighted new treatments and research in pediatric skin conditions, emphasizing collaboration and innovation.

Combining PEMF with PBST is more effective for hair regrowth than PBST alone.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Long-lasting symptoms like fatigue and breathlessness can persist after COVID-19, requiring ongoing medical follow-up.

Rosemary essential oil can improve mood, sleep, and cognitive function but may cause allergies, so use it carefully.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Sunscreen technology is improving with new ingredients and methods to better protect skin from sun damage.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Stem cell transplantation shows promise for treating diseases but faces challenges like safety, ethics, and cost.

Lower LDL-c levels predict higher COVID-19 mortality.

Long COVID patients may have hormonal imbalances linked to their symptoms.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.